Drugs Made In America Acquisition Corp. Ordinary Shares

NASDAQ:DMAA

Shell Companies

Financial Services
$10.90 +0.00%

+$0.00 today

Market cap
$264.62M
Beta
0.00
P/E (TTM)
36.7
EPS (TTM)
$0.29
52W Low $10.17High $10.63

Volume 0.00M

Average 0.11M

DMAA Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

Drugs Made In America Acquisition Corp. Ordinary SharesNASDAQ: DMAA

Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026

Other income / expenses grows, but more slowly than its trailing trend

Q1 FY2026 other income / expenses of $2.11M rose 33.3% year over year, behind the +485.6% change in trailing-twelve-month other income / expenses. Sequentially, it fell 8.2% from the prior quarter.

What to watch

Whether quarterly growth recovers from +33.3% toward the trailing-twelve-month pace of +485.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$2.11M-8.2% QoQ
Last fiscal yearDec 2025
$8.76M— YoY
LTMMar 2026
$9.28M+485.6% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+33.3%——
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

USD · from the income statement

Latest · FY2025
8.76M USD
Year-over-year change
—

Other Income / Expenses vs competitors

How DMAA compares with its peers on the latest reported figures

  • DMAA's LTM Mar 2026 other income / expenses of $9.28M is the 6th highest of the 10 companies compared; the peer median is $9.36M.
  • Its year-over-year change of +485.6% is the highest of 4, against a peer median of +21.8%.
DMAA Competitors Peer median
Other Income / Expenses for DMAA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TACOUBerto Acquisition Corp. UnitLTM Mar 2026$11.22M ———
TACOBerto Acquisition Corp.LTM Mar 2026$11.22M ———
TACHTitan Acquisition Corp.LTM Mar 2026$10.77M ———
SIMASIM Acquisition Corp. ILTM Mar 2026$9.49M +21.8%——
MLACMountain Lake Acquisition Corp.LTM Mar 2026$9.36M +230.4%+26.2%—
DMAADrugs Made In America Acquisition Corp. Ordinary SharesLTM Mar 2026$9.28M +485.6%——
OYSEOyster Enterprises II Acquisition CorpLTM Mar 2026$8.5M ———
RTACRenatus Tactical Acquisition Corp I Class A Ordinary SharesLTM Mar 2026$8.17M ———
ALFCenturion Acquisition Corp.LTM Mar 2026$7.07M -20.7%——
LOKVLive Oak Acquisition Corp. V Class A Ordinary SharesLTM Mar 2026-$7.26M ———
Peer median (excluding DMAA) $9.36M+21.8%+26.2%—

Competitors are the stored peer set for DMAA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD

Drugs Made In America Acquisition Corp. Ordinary Shares

NASDAQ:DMAA

Intrinsic Alpha fair value

Locked

Current Price

$10.90

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.